Apogee Therapeutics, Inc. - COMMON STOCK (APGE)
CUSIP: 03770N101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 61,257,262
- Total 13F shares
- 57,837,483
- Share change
- -3,654,463
- Total reported value
- $2,511,890,310
- Put/Call ratio
- 97%
- Price per share
- $43.43
- Number of holders
- 180
- Value change
- -$147,322,983
- Number of buys
- 90
- Number of sells
- 87
Quarterly Holders Quick Answers
What is CUSIP 03770N101?
CUSIP 03770N101 identifies APGE - Apogee Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03770N101:
Top shareholders of APGE - Apogee Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
14%
|
8,493,321
|
$317,310,473 | — | 31 Mar 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
15%
from 13D/G
|
7,493,626
|
$279,961,868 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9%
|
5,485,754
|
$204,947,769 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
5.5%
|
2,518,725
|
$109,396,539 | $0 | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
4.4%
|
2,712,097
|
$101,323,944 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.8%
|
2,339,563
|
$87,406,074 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
2,082,606
|
$77,806,160 | — | 31 Mar 2025 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.3%
|
2,048,647
|
$76,537,452 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
1,793,833
|
$71,286,145 | — | 31 Mar 2025 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
2.7%
|
1,640,180
|
$61,277,126 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.6%
|
1,569,491
|
$58,636,184 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
2.5%
|
1,540,362
|
$57,547,924 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,313,750
|
$49,081,700 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.1%
|
1,280,950
|
$47,856,292 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.9%
|
1,151,199
|
$43,008,795 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.8%
|
1,122,767
|
$41,946,575 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
1,061,053
|
$39,640,940 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.6%
|
962,631
|
$35,963,893 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.6%
|
961,707
|
$35,929,374 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
876,076
|
$32,730,189 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
835,695
|
$31,228,312 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
821,850
|
$30,705,000 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
727,000
|
$27,160,720 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
701,909
|
$26,223,320 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.97%
|
594,994
|
$22,228,976 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.9%
|
550,000
|
$20,548,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.85%
|
519,939
|
$19,424,957 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.81%
|
498,625
|
$18,628,630 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.7%
|
425,880
|
$15,910,876 | — | 31 Mar 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.69%
|
421,796
|
$15,758,299 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.64%
|
392,488
|
$14,663,352 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
314,478
|
$11,748,898 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.48%
|
293,757
|
$10,974,763 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
290,699
|
$10,860,514 | — | 31 Mar 2025 | |
| Commodore Capital LP |
13F
|
Company |
0.47%
|
290,000
|
$10,834,400 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
271,879
|
$10,157,399 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
260,335
|
$9,726,116 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.41%
|
252,135
|
$9,419,764 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.38%
|
232,983
|
$8,704,245 | — | 31 Mar 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.37%
|
229,675
|
$8,580,658 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
214,231
|
$8,003,654 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
200,000
|
$7,472,000 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
0.32%
|
193,895
|
$7,243,917 | — | 31 Mar 2025 | |
| Blackstone Inc. |
13F
|
Company |
0.3%
|
183,747
|
$6,864,788 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
167,991
|
$6,276,144 | — | 31 Mar 2025 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.21%
|
127,208
|
$4,752,490 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.18%
|
112,730
|
$4,211,593 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.18%
|
110,855
|
$4,141,543 | — | 31 Mar 2025 | |
| Allostery Investments LP |
13F
|
Company |
0.18%
|
110,000
|
$4,109,600 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.18%
|
109,410
|
$4,087,558 | — | 31 Mar 2025 |
Institutional Holders of Apogee Therapeutics, Inc. - COMMON STOCK (APGE) as of Q2 2025
As of 30 Jun 2025,
Apogee Therapeutics, Inc. - COMMON STOCK (APGE) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,837,483 shares.
The largest 10 holders included
VR ADVISER, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, BlackRock, Inc., Driehaus Capital Management LLC, VANGUARD GROUP INC, Fairmount Funds Management LLC, BRAIDWELL LP, and ALLIANCEBERNSTEIN L.P..
This page lists
181
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
165
Q2 2025 holders
180
Holder diff
15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.